German General Merchandise and Department Stores Stock News

XTRA:FME
XTRA:FMEHealthcare

Fresenius Medical Care Refocuses Symvess Rights And Vascular Access Ambitions

Fresenius Medical Care (XTRA:FME) has amended its distribution agreement with Humacyte, Inc. regarding Symvess, an investigational acellular tissue engineered vessel. The revision realigns ex U.S. rights to Symvess and reshapes how the two companies coordinate on access to this advanced vascular product outside the United States. For you as an investor, this move sits at the intersection of medical technology and chronic kidney care, where XTRA:FME is a major global provider. Access to next...
XTRA:BMW
XTRA:BMWAuto

Is It Time To Revisit BMW (XTRA:BMW) After This Year’s Share Price Slide?

If you are wondering whether Bayerische Motoren Werke is attractively priced right now, the starting point is understanding how the current share price lines up against a grounded estimate of value. The stock closed at €77.92 most recently, with a 1.8% decline over the last 7 days, a 1.7% decline over 30 days, a 19.1% decline year to date, but a 9.9% gain over the past year. These mixed returns give you a picture of a share price that has shifted meaningfully over different time frames,...
XTRA:ALV
XTRA:ALVInsurance

Assessing Allianz (XTRA:ALV) Valuation After Recent Share Price Momentum And Analyst Targets

Allianz at a Glance: Recent Returns and Business Mix Allianz (XTRA:ALV) has drawn attention after a period where the share price shows a 1 day return of 1.1%, a 7 day return of 0.3%, and around 5.7% over the past month. For context, Allianz reports annual revenue of €113.2b and net income of €10.6b, with annual revenue growth of 9.1% and net income growth of 6%. The group operates across property casualty, life and health insurance, and asset management. See our latest analysis for...
XTRA:WCH
XTRA:WCHChemicals

A Look At Wacker Chemie (XTRA:WCH) Valuation After Strong Q1 EBITDA And Upgraded Sales Outlook

Wacker Chemie (XTRA:WCH) has caught investor attention after reporting Q1 EBITDA of €173 million, a 45% year-over-year increase, supported by its PACE cost program and upgraded full-year 2026 sales expectations. See our latest analysis for Wacker Chemie. Wacker Chemie’s share price has moved to €93.65, with a 30-day share price return of 14.14% and a 90-day return of 35.53%. The 1-year total shareholder return of 44.43% contrasts with weaker 3 and 5-year total returns, suggesting momentum has...
XTRA:HOT
XTRA:HOTConstruction

Assessing HOCHTIEF (XTRA:HOT) Valuation After Dividend Plans, Czech Airport Contract And Profit Update

HOCHTIEF (XTRA:HOT) has drawn fresh attention after confirming its upcoming dividend schedule, including the ex-dividend date, as well as securing a €220 million Czech airport modernization contract and reporting rising operational profits with unchanged FY25 guidance. See our latest analysis for HOCHTIEF. After HOCHTIEF confirmed its dividend timetable and the €220 million Czech airport project, the share price has moved to €457.2, with a 30 day share price return of 12.56% and year to date...
XTRA:P911
XTRA:P911Auto

Porsche Cayenne Coupé Electric Launch Tests P911 Valuation And Growth Story

Porsche has unveiled the all electric Cayenne Coupé at a world premiere event in Beijing. The launch extends electrification to one of Porsche's core SUV nameplates within the Cayenne range. The new model introduces updated design elements and e performance options in the premium SUV segment. For investors watching Dr. Ing. h.c. F. Porsche (XTRA:P911), the Cayenne Coupé Electric adds a fresh catalyst to a share price that last closed at €41.25. Over the past month the stock has returned...
XTRA:PAH3
XTRA:PAH3Auto

Porsche Automobil Holding (XTRA:PAH3) Valuation Check After €7.5b Shelf Registration Filing

Why Porsche Automobil Holding (XTRA:PAH3) just filed a €7.5b shelf Porsche Automobil Holding (XTRA:PAH3) has registered up to €7.5b in notes, a sizeable shelf that gives the company flexibility to issue debt as financing needs or portfolio opportunities arise. See our latest analysis for Porsche Automobil Holding. Despite the €7.5b shelf filing, Porsche Automobil Holding’s share price return over the past year has been weak, with a 23.47% year to date share price decline and a 56.22% five...
XTRA:RHM
XTRA:RHMAerospace & Defense

Is It Time To Reassess Rheinmetall (XTRA:RHM) After Recent Share Price Pullback?

Wondering if Rheinmetall at €1,355.80 is pricing in too much optimism or leaving room on the table for value focused investors like you? The stock is up 2.8% over the last week, but shows a 13.7% decline over 30 days, a 15.4% decline year to date, and a 13.5% decline over the past year, all following a very large 3 year gain and an even larger 5 year gain. Recent coverage has focused on Rheinmetall's position in defense and capital goods, which often draws attention whenever sector sentiment...
XTRA:R3NK
XTRA:R3NKMachinery

A Look At RENK Group (XTRA:R3NK) Valuation After Its Newly Announced Annual Dividend

RENK Group (XTRA:R3NK) has announced an annual dividend of €0.58 per share, with an ex dividend date of 11 June 2026, a record date of 12 June, and payment on 15 June 2026. See our latest analysis for RENK Group. The dividend announcement comes as RENK Group's share price sits at €53.97, with relatively muted short term share price moves and a slightly negative year to date share price return, alongside a modest 1 year total shareholder return decline that suggests momentum has cooled...
XTRA:BAS
XTRA:BASChemicals

BASF (XTRA:BAS) Margins At 2.4% Challenge Rich 33.3x P/E Bullish Narratives

BASF (XTRA:BAS) has just opened 2026 with Q1 numbers that cap a year where trailing twelve month revenue sat at about €59.7b and basic EPS came in at €1.61. Over recent quarters, the company has seen revenue move from €17.6b and EPS of €1.53 in Q1 2024 to €14.0b and EPS of €0.57 in Q4 2025, with trailing net income from continuing operations at €1.43b across the last reported twelve months. With net profit margins over the past year at 2.4% and earnings growth of 26.6% supported by forecasts...
XTRA:SAP
XTRA:SAPSoftware

SAP Clean Core Partner Win Meets Valuation Gap And Mixed Momentum

Precisely Automate has received SAP Clean Core Certification for high volume automation in S/4HANA Cloud Private Edition. The certification confirms that Precisely Automate can support automation at scale while keeping S/4HANA deployments compliant with SAP clean core principles. This development focuses on customers moving to S/4HANA Cloud Private Edition who want to reduce technical debt and preserve upgrade safety. For investors tracking SAP (XTRA:SAP), this update sits against a...
DB:LNSX
DB:LNSXTransportation

Allane (DB:LNSX) Quarterly Profit Of €8.7 Million Tests Longer Term Bearish Loss Narrative

Allane (DB:LNSX) has just released its FY 2025 numbers, reporting third quarter revenue of €233.2 million and basic EPS of €0.42, while trailing twelve month figures show total revenue of €827.7 million and a loss of €3.1 million on a basic EPS of €0.15. Over recent periods, the company has seen quarterly revenue move from €184.0 million in Q2 2024 to €233.2 million in Q3 2025, with EPS ranging from a loss of €0.72 in Q2 2024 to €0.42 in Q3 2025. This provides a clearer view of how the top...
XTRA:BAYN
XTRA:BAYNPharmaceuticals

Is It Too Late To Consider Bayer (XTRA:BAYN) After A 59.8% One-Year Surge?

Investors may be asking whether Bayer at €38.05 is still offering value after a strong run, or if most of the opportunity has already been priced in. The stock has returned 59.8% over the last year, while the 7-day and 30-day returns of a 1.2% decline and a 4.1% decline hint at some recent hesitation, with year-to-date performance roughly flat at 0.1%. Recent news around Bayer has focused on its ongoing transformation as a large pharmaceuticals and life sciences group and how that is being...
XTRA:BFSA
XTRA:BFSACommercial Services

Befesa (XTRA:BFSA) Q1 2026 Margin Strength Supports Bullish Profitability Narrative

Befesa (XTRA:BFSA) Q1 2026 earnings snapshot Befesa (XTRA:BFSA) has opened 2026 with Q1 revenue of €285.2 million and basic EPS of €0.52, set against trailing twelve month revenue of €1.16 billion and EPS of €2.06 that came with 37.6% earnings growth and a net profit margin of 7.1% compared with 4.8% a year earlier. Over the past year, revenue has moved from €1.25 billion in the period ending Q1 2025 to €1.16 billion on a trailing basis, while EPS has shifted from €1.50 to €2.06 as earnings...
XTRA:MBG
XTRA:MBGAuto

Is Mercedes-Benz Group (XTRA:MBG) Offering Value After Recent Share Price Weakness

If you are wondering whether Mercedes-Benz Group shares are offering good value right now, the key is to separate price moves from what the underlying business may be worth. The stock last closed at €49.59, with returns of 8.2% over 1 year, 18.0% over 5 years, and shorter term moves of a 0.4% decline over 7 days, a 5.9% decline over 30 days, and a 19.9% decline year to date. Recent coverage has focused on Mercedes-Benz Group as a core name in the European auto sector, with investors closely...
XTRA:DHL
XTRA:DHLLogistics

Has The Recent Rally Left Deutsche Post (XTRA:DHL) Shares Fully Priced?

This article examines whether Deutsche Post shares still offer value at current levels or whether the recent strength has already priced in the upside, using the available numbers to assess the stock. Over the last week the share price return is 5.4%, with 9.2% over the past month, 7.4% year to date and 38.7% over the past year. These figures can influence how investors think about both opportunity and risk. Recent coverage has focused on Deutsche Post as a global logistics and parcel...
XTRA:ACT
XTRA:ACTChemicals

AlzChem Group (XTRA:ACT) Margin Improvement To 11% Tests Bullish Growth Narratives

AlzChem Group (XTRA:ACT) has opened 2026 with fresh numbers, coming off Q4 2025 revenue of €136.15 million and net income of €16.739 million, which translated into basic EPS of €1.66. Over recent quarters, the company has seen revenue move from €137.24 million in Q4 2024 to a range between €141.07 million and €151.07 million through 2025, while quarterly EPS tracked between €1.21 and €1.66, giving investors a consistent read on both the top and bottom line. With trailing net profit margins at...
XTRA:DTE
XTRA:DTETelecom

Is It Time To Reconsider Deutsche Telekom (XTRA:DTE) After The Recent Share Price Slide

Investors may be wondering whether Deutsche Telekom's share price reflects its true worth, or if the market is mispricing this telecom heavyweight right now. The stock last closed at €27.57, with a 10.4% decline over 30 days and a 10.3% decline over 1 year, despite longer term returns of 41.7% over 3 years and 96.4% over 5 years, which hint at a very different picture. Recent headlines have focused on Deutsche Telekom's position within the European telecom sector, including its role in...
XTRA:LHA
XTRA:LHAAirlines

Is Lufthansa (XTRA:LHA) Pricing Look Attractive After Recent Share Price Weakness?

If you are wondering whether Deutsche Lufthansa’s €7.33 share price offers value or risk at today’s levels, key clues sit in how the market is currently weighing its fundamentals. The stock has returned 1.1% over the last 7 days, while the 30 day performance is a 2.3% decline and the year to date move is a 14.6% decline, set against an 18.9% gain over the past year and a 12.6% decline over 3 years. Investors have been reacting to ongoing sector wide themes such as capacity planning, cost...